JPWO2020004014A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020004014A5
JPWO2020004014A5 JP2020527369A JP2020527369A JPWO2020004014A5 JP WO2020004014 A5 JPWO2020004014 A5 JP WO2020004014A5 JP 2020527369 A JP2020527369 A JP 2020527369A JP 2020527369 A JP2020527369 A JP 2020527369A JP WO2020004014 A5 JPWO2020004014 A5 JP WO2020004014A5
Authority
JP
Japan
Prior art keywords
ascorbic acid
glucoside
ergothioneine
muscle differentiation
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020527369A
Other languages
English (en)
Japanese (ja)
Other versions
JP7759724B2 (ja
JPWO2020004014A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/023114 external-priority patent/WO2020004014A1/ja
Publication of JPWO2020004014A1 publication Critical patent/JPWO2020004014A1/ja
Publication of JPWO2020004014A5 publication Critical patent/JPWO2020004014A5/ja
Priority to JP2023203550A priority Critical patent/JP2024026241A/ja
Priority to JP2025114256A priority patent/JP2025148417A/ja
Application granted granted Critical
Publication of JP7759724B2 publication Critical patent/JP7759724B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020527369A 2018-06-29 2019-06-11 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用 Active JP7759724B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023203550A JP2024026241A (ja) 2018-06-29 2023-12-01 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
JP2025114256A JP2025148417A (ja) 2018-06-29 2025-07-07 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018124613 2018-06-29
JP2018124613 2018-06-29
PCT/JP2019/023114 WO2020004014A1 (ja) 2018-06-29 2019-06-11 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023203550A Division JP2024026241A (ja) 2018-06-29 2023-12-01 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Publications (3)

Publication Number Publication Date
JPWO2020004014A1 JPWO2020004014A1 (ja) 2021-07-15
JPWO2020004014A5 true JPWO2020004014A5 (enExample) 2022-06-17
JP7759724B2 JP7759724B2 (ja) 2025-10-24

Family

ID=68986429

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020527369A Active JP7759724B2 (ja) 2018-06-29 2019-06-11 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
JP2023203550A Pending JP2024026241A (ja) 2018-06-29 2023-12-01 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
JP2025114256A Pending JP2025148417A (ja) 2018-06-29 2025-07-07 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023203550A Pending JP2024026241A (ja) 2018-06-29 2023-12-01 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用
JP2025114256A Pending JP2025148417A (ja) 2018-06-29 2025-07-07 エルゴチオネイン、アスコルビン酸２－グルコシド、アスコルビン酸、およびそれらの組み合わせの筋分化促進作用

Country Status (6)

Country Link
US (1) US12454678B2 (enExample)
EP (1) EP3816278A4 (enExample)
JP (3) JP7759724B2 (enExample)
CN (1) CN112352046A (enExample)
TW (1) TWI815907B (enExample)
WO (1) WO2020004014A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022230487A1 (ja) * 2021-04-26 2022-11-03 サントリーホールディングス株式会社 赤血球及び／又はヘモグロビン増加用組成物
WO2022242711A1 (en) * 2021-05-20 2022-11-24 Nanjing Nutrabuilding Bio-Tech Co., Ltd. Methods for ameliorating and preventing age‐related muscle degeneration
JP7569818B2 (ja) * 2022-03-11 2024-10-18 キッコーマン株式会社 エルゴチオネインを光に対し安定化させた液体組成物
CN120659607A (zh) * 2023-02-16 2025-09-16 三得利控股株式会社 含有麦角硫因的肌肉萎缩抑制用组合物及Src酪氨酸激酶阻碍用组合物
DE102023131771B3 (de) 2023-09-15 2025-02-06 Esspen Gmbh Verfahren und Vorrichtung zur Verarbeitung medizintechnischer Bilddaten im Zusammenhang mit einer Trepanation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003243266A1 (en) * 2002-05-20 2003-12-12 Oxis International, Inc. Method of reducing incidence diabetic embryopathy with l-ergothioneine
CA2683858A1 (en) * 2007-04-12 2008-10-23 Oxis International, Inc. Ergothioneine and/or its derivatives as a cell preservative
FR2924334B1 (fr) * 2007-11-30 2016-03-25 Lvmh Rech Composition cosmetique comprenant l'acide 2-glucoside ascorbique et l'ergothioneine.
US20110262965A1 (en) * 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
US20120141611A1 (en) 2010-12-05 2012-06-07 Oxis International Inc. Methods and compositions using ergothioneine to treat a variety of health related factors
WO2014004647A1 (en) * 2012-06-26 2014-01-03 Entia Biosciences, Inc. A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2
TWI549696B (zh) * 2014-09-05 2016-09-21 中國醫藥大學 麥角硫因應用於活化細胞之Ｎｒｆ２訊息途徑之用途

Similar Documents

Publication Publication Date Title
JPWO2020004014A5 (enExample)
Warinner et al. Ancient human microbiomes
EP1937091A4 (en) GRAPE EXTRACT, GRAPE EXTRACT FOOD ADDITIVE, AND METHOD THEREFOR
JP2014158488A5 (enExample)
MY177340A (en) Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor
WO2012060579A3 (ko) 항균용 유산균 사균체 및 이의 제조방법
EP4559902A3 (en) Kdm1a inhibitors for the treatment of disease
WO2015109362A3 (en) Method for reducing total gas production and/or methane production in a ruminant animal
WO2015048346A3 (en) Compositions and formulations for prevention and treatment of diabetes and obesity, and methods of production and use thereof in glucose and caloric control
EP1941892A3 (en) Anti-allergy lactic acid bacteria
WO2008097842A3 (en) Ingredient systems comprising trehalose, food products containing trehalose, and methods of making same
HK1200062A1 (en) Dairy based compositions with low lps
PH12015500634B1 (en) Method for preparing natural neutral flavor
MY184520A (en) Method for preparing natural kokumi flavor
HK1208993A1 (en) Obesity animal model and methods for making and using thereof
JP2016065039A5 (enExample)
PH12015500631A1 (en) Method for preparing natural beef flavor
WO2018020323A3 (en) Materials and methods for treatment of fatty acid disorders
CN106471121A8 (zh) 减少功能蛋白的水平基因转移
WO2012124978A3 (ko) 3차원 세포배양으로 수득한 조정 배지를 유효성분으로 포함하는 허혈성 질환 치료용 약학적 조성물
EA202090556A1 (ru) Композиция алкогольного напитка, содержащая bacillus coagulans
MY185916A (en) Flavor modulator containing 4-alkoxycinnamaldehyde as active ingredient
JP2017190308A5 (enExample)
WO2011037712A3 (en) Nutritional compositions including theanine and exogenous nucleotides
WO2014092564A8 (en) Nutritional composition with non digestible oligosaccharides